SCHEMBL17078459

SCHEMBL17078459

COC(=O)c1ccc(CN2[C@H](C)CN(C(=O)Cc3cccc(Cl)c3)C[C@@H]2C)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.58
▸ HDAC6 Q9UBN7 1/20 0.58
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ ATM Q13315 1/20 0.43
▸ PTGDR2 Q9Y5Y4 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ OPRK1 P41145 2/20 0.41
▸ OPRD1 P41143 1/20 0.41
▸ GAA P10253 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ SIGMAR1 Q99720 2/20 0.40
▸ CXCR6 O00574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17079030 0.89 HDAC1 (0.47) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL20420890 0.88 HDAC1 (0.58) HDAC1HDAC6MEN1KMT2AATM
SCHEMBL18701038 0.88 ALDH1A1 (0.48) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL17078717 0.88 TSHR (0.47) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL17078583 0.88 HDAC1 (0.76) HDAC1HDAC6MEN1KMT2AATM
SCHEMBL17078963 0.86 HDAC1 (0.77) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL20432640 0.86 HDAC1 (0.54) HDAC1HDAC6MEN1KMT2AATM
SCHEMBL17078444 0.85 HDAC1 (0.54) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL17078684 0.84 ROCK2 (0.43) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL17078815 0.83 HDAC1 (0.58) HDAC1HDAC6MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287255-B2 Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2019-05-14 — — US disclosed
EP-3116859-B1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2018-08-01 — — EP disclosed
US-20170096405-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2017-04-06 — — US disclosed
EP-3116859-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2017-01-18 — — EP disclosed
WO-2015137750-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-09-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10287255-B2 Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same HDAC6, HDAC1, HDAC11 HDAC1 2/4885HDAC6 1/4885MEN1 2537/4885
US-20170096405-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME HDAC6, HDAC1, HDAC5 HDAC1 2/4885HDAC6 1/4885MEN1 3278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback